The estimated Net Worth of Advisors Llcperceptive Life... is at least $51.2 Million dollars as of 11 January 2024. Advisors Life owns over 3,410,713 units of Solid Biosciences Inc stock worth over $51,183,207 and over the last few years Advisors sold SLDB stock worth over $0.
Advisors has made over 1 trades of the Solid Biosciences Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Advisors bought 3,410,713 units of SLDB stock worth $18,861,243 on 11 January 2024.
The largest trade Advisors's ever made was buying 3,410,713 units of Solid Biosciences Inc stock on 11 January 2024 worth over $18,861,243. On average, Advisors trades about 3,410,713 units every 0 days since 2024. As of 11 January 2024 Advisors still owns at least 6,833,539 units of Solid Biosciences Inc stock.
You can see the complete history of Advisors Life stock trades at the bottom of the page.
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Solid Biosciences Inc executives and other stock owners filed with the SEC include: